» Articles » PMID: 39124845

Gastrointestinal and Hepatobiliary Manifestations Associated with Untreated Celiac Disease in Adults and Children: A Narrative Overview

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Aug 10
PMID 39124845
Authors
Affiliations
Soon will be listed here.
Abstract

Celiac disease (CeD) is a chronic inflammatory disease of the small intestine, produced by ingesting dietary gluten products in susceptible people. Gluten causes an impairment of the mucosal surface and, consequently, an abnormal absorption of nutrients. Although malabsorption of essential nutrients is a major risk factor for various CeD-associated morbidities, genetic, immunological, and environmental factors also play an important role. The clinical presentation of CeD widely varies and can range from asymptomatic to full-blown symptoms due to the multi-system nature of CeD. The typical gastrointestinal (GI) manifestations of CeD include abdominal pain, diarrhea, bloating, and weight loss, but several hepatobiliary manifestations and a poor nutritional status have also been described. Currently, a gluten-free diet (GFD) is the only current evidence-based treatment that leads to the complete recovery of mucosal damage and the reversibility of its progression. Conversely, undiagnosed CeD might have severe consequences in children as well as in adult patients. This narrative overview aims to characterize the GI and hepatobiliary manifestations, nutritional deficiencies, and delayed pediatric development associated with unrecognized CeD in order to identify it promptly. Moreover, the role of GFD and how it could prevent long-term complications of CeD are described.

Citing Articles

Celiac Disease: Beyond Diet and Food Awareness.

Herrera-Quintana L, Navajas-Porras B, Vazquez-Lorente H, Hinojosa-Nogueira D, Corrales-Borrego F, Lopez-Garzon M Foods. 2025; 14(3).

PMID: 39941971 PMC: 11817883. DOI: 10.3390/foods14030377.


Effects of a Gluten-Free Diet on Brain Bioelectrical Activity and Neurological Symptoms in Children with Celiac Disease: A Study Using EEG Assessment.

Zochowska-Sobaniec M, Jarocka-Cyrta E, Lotowska J, Sobaniec P J Clin Med. 2025; 14(3).

PMID: 39941394 PMC: 11818230. DOI: 10.3390/jcm14030725.

References
1.
Narciso-Schiavon J, Schiavon L . To screen or not to screen? Celiac antibodies in liver diseases. World J Gastroenterol. 2017; 23(5):776-791. PMC: 5296194. DOI: 10.3748/wjg.v23.i5.776. View

2.
De Giuseppe R, Bergomas F, Loperfido F, Giampieri F, Preatoni G, Calcaterra V . Could Celiac Disease and Overweight/Obesity Coexist in School-Aged Children and Adolescents? A Systematic Review. Child Obes. 2023; 20(1):48-67. DOI: 10.1089/chi.2022.0035. View

3.
Alsaadi D, Shah N, Charabaty A, Atkins M . A case of checkpoint inhibitor-induced celiac disease. J Immunother Cancer. 2019; 7(1):203. PMC: 6683380. DOI: 10.1186/s40425-019-0694-x. View

4.
Setavand Z, Ekramzadeh M, Honar N . Evaluation of malnutrition status and clinical indications in children with celiac disease: a cross-sectional study. BMC Pediatr. 2021; 21(1):147. PMC: 8006373. DOI: 10.1186/s12887-021-02621-3. View

5.
Helander H, Fandriks L . Surface area of the digestive tract - revisited. Scand J Gastroenterol. 2014; 49(6):681-9. DOI: 10.3109/00365521.2014.898326. View